JW (Cayman) Therapeutics Co. Ltd

SEHK:2126 Stock Report

Market Cap: HK$686.0m

JW (Cayman) Therapeutics Dividend

Dividend criteria checks 0/6

JW (Cayman) Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-HK$1.90
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Feb 03
JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 2126's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2126's dividend payments have been increasing.


Dividend Yield vs Market

JW (Cayman) Therapeutics Dividend Yield vs Market
How does 2126 dividend yield compare to the market?
SegmentDividend Yield
Company (2126)n/a
Market Bottom 25% (HK)3.4%
Market Top 25% (HK)8.3%
Industry Average (Biotechs)1.1%
Analyst forecast in 3 Years (2126)0%

Notable Dividend: Unable to evaluate 2126's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 2126's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate 2126's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 2126 has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.